USP Pharmaceutical Analytical Impurities

(1-{2-[(2,4-Dimethylphenyl)sulfinyl]phenyl}piperazine hydrochloride)

(4-[2-(2,4-Dimethylphenylthio)phenyl]piperazine-1-carbaldehyde)

(N1-{2-[(2,4-dimethylphenyl)thio]phenyl}ethane-1,2-diamine hydrochloride)

(2-[(2,4-dimethylphenyl)thio]aniline hydrobromide)

(3-Methyl 5-(2-(methylamino)ethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate)

(3-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}propanoic acid)

(3-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}-N-isopropylpropionamide)

(1-[(2R,3S,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine S-oxide)

(Methyl 3-{4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}propionate)

((S)-4-Chloro-3-{4-[(tetrahydrofuran-3-yl)oxy]benzyl}phenol)

(3-Phenylpyrazin-2-ol)

(1-Benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]piperidine)

(2-[(2,6-Dimethylphenyl)amino]-N,N-diethyl-2-oxoethan-1-amine oxide)

(N-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide hydrochloride)

(2-(Diethylamino)-N-(2,4-dimethylphenyl)acetamide hydrochloride)

(3-{2-[4-(Benzisoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)

(Isopropyl [(R)-{[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-D-alaninate)

(Isopropyl [(S)-{[(2R,3R,4R,5R)-5-[2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl]oxy}(phenoxy)phosphoryl]-L-alaninate)

(Isopropyl [(R)-{[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]-L-alaninate)

([(2R,3R,4R,5R)-5-[2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methyl dihydrogen phosphate)

((S)-N-(1-Amino-1-oxopropan-2-yl)-4-[(3-fluorobenzyl)oxy]benzamide)

(4,4'-{[(Piperazine-1,4-dicarbonyl)bis(4-fluoro-3,1-phenylene)]bis(methylene)}bis(phthalazin-1(2H)-one))